Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionFifth Third Bancorp
Latest Disclosed Ownership3,438 shares
Latest Disclosed Value $ 15,472
Fifth Third Bancorp reports 57.71% increase in ownership of MYGN / Myriad Genetics, Inc.

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 3,438 shares of Myriad Genetics, Inc. (US:MYGN) valued at $15,471 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 2,180 shares of Myriad Genetics, Inc.. This represents a change in shares of 57.71% during the quarter. The current value of the position is $15,712 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F MYRIAD GENETICS COM 62855J104 3,438 1,258 57.71 15 15.38 0.0000
2026-02-02 2025-12-31 13F MYRIAD GENETICS COM 62855J104 2,180 131 6.39 13 -7.14 0.0000
2025-11-07 2025-09-30 13F MYRIAD GENETICS COM 62855J104 2,049 -218 -9.62 15 16.67 0.0000
2025-07-15 2025-06-30 13F MYRIAD GENETICS COM 62855J104 2,267 -44,222 -95.12 12 -97.09 0.0000
2025-04-15 2025-03-31 13F MYRIAD GENETICS COM 62855J104 46,489 -8,826 -15.96 412 -45.65 0.0016
2025-01-21 2024-12-31 13F MYRIAD GENETICS COM 62855J104 55,315 -23,296 -29.63 758 -64.79 0.0028
2024-10-17 2024-09-30 13F MYRIAD GENETICS COM 62855J104 78,611 -3,143 -3.84 2,153 7.70 0.0078
2024-07-22 2024-06-30 13F MYRIAD GENETICS COM 62855J104 81,754 1,139 1.41 2,000 16.36 0.0076
2024-04-23 2024-03-31 13F MYRIAD GENETICS COM 62855J104 80,615 2,812 3.61 1,719 15.38 0.0067
2024-01-19 2023-12-31 13F MYRIAD GENETICS COM 62855J104 77,803 3,695 4.99 1,489 25.34 0.0063
2023-10-31 2023-09-30 13F MYRIAD GENETICS COM 62855J104 74,108 -386 -0.52 1,189 -31.17 0.0055
2023-07-26 2023-06-30 13F MYRIAD GENETICS COM 62855J104 74,494 5,324 7.70 1,727 7.47 0.0076
2023-04-24 2023-03-31 13F MYRIAD GENETICS COM 62855J104 69,170 2,835 4.27 1,607 66.94 0.0075
2023-01-25 2022-12-31 13F MYRIAD GENETICS COM 62855J104 66,335 7,835 13.39 963 -13.80 0.0046
2022-10-25 2022-09-30 13F MYRIAD GENETICS COM 62855J104 58,500 33,539 134.37 1,116 145.81 0.0058
2022-08-04 2022-06-30 13F MYRIAD GENETICS COM 62855J104 24,961 3,142 14.40 454 -17.45 0.0022
2022-04-19 2022-03-31 13F MYRIAD GENETICS COM 62855J104 21,819 4,795 28.17 550 17.02 0.0022
2022-02-01 2021-12-31 13F MYRIAD GENETICS COM 62855J104 17,024 3,056 21.88 470 4.21 0.0018
2021-10-15 2021-09-30 13F MYRIAD GENETICS COM 62855J104 13,968 2,909 26.30 451 33.43 0.0020
2021-08-06 2021-06-30 13F MYRIAD GENETICS COM 62855J104 11,059 -1,555 -12.33 338 -11.98 0.0015
2021-05-07 2021-03-31 13F MYRIAD GENETICS COM 62855J104 12,614 987 8.49 384 66.96 0.0018
2021-02-16 2020-12-31 13F MYRIAD GENETICS COM 62855J104 11,627 4,302 58.73 230 139.58 0.0011
2020-11-09 2020-09-30 13F MYRIAD GENETICS COM 62855J104 7,325 295 4.20 96 20.00 0.0005
2020-08-05 2020-06-30 13F MYRIAD GENETICS COM 62855J104 7,030 3,715 112.07 80 70.21 0.0005
2020-05-05 2020-03-31 13F MYRIAD GENETICS COM 62855J104 3,315 3,315 47 0.0003
2016-11-10 2016-09-30 13F MYRIAD GENETICS COM 62855J104 0 -91 -100.00 0 -100.00
2016-08-11 2016-06-30 13F MYRIAD GENETICS COM 62855J104 91 0 0.00 3 0.00 0.0000
2016-05-13 2016-03-31 13F MYRIAD GENETICS COM 62855J104 91 0 0.00 3 -25.00 0.0000
2016-02-16 2015-12-31 13F MYRIAD GENETICS COM 62855J104 91 0 0.00 4 33.33 0.0000
2015-11-13 2015-09-30 13F MYRIAD GENETICS COM 62855J104 91 0 0.00 3 0.00 0.0000
2015-08-14 2015-06-30 13F MYRIAD GENETICS COM 62855J104 91 -187 -67.27 3 -70.00 0.0000
2015-05-14 2015-03-31 13F MYRIAD GENETICS COM 62855J104 278 0 0.00 10 11.11 0.0001
2015-02-13 2014-12-31 13F MYRIAD GENETICS COM 62855J104 278 -281 -50.27 9 -59.09 0.0001
2014-11-17 2014-09-30 13F MYRIAD GENETICS COM 62855J104 559 -504 -47.41 22 -46.34 0.0002
2014-08-14 2014-06-30 13F MYRIAD GENETICS COM 62855J104 1,063 -7,688 -87.85 41 -86.29 0.0004
2014-05-15 2014-03-31 13F MYRIAD GENETICS COM 62855J104 8,751 -43,817 -83.35 299 -72.89 0.0028
2014-02-14 2013-12-31 13F MYRIAD GENETICS COM 62855J104 52,568 19,774 60.30 1,103 43.06 0.0107
2013-11-14 2013-09-30 13F MYRIAD GENETICS COM 62855J104 32,794 -1,078 -3.18 771 -15.27 0.0079
2013-08-14 2013-06-30 13F MYRIAD GENETICS COM 62855J104 33,872 33,872 910 0.0097
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.